J Korean Med Assoc.  2005 Sep;48(9):886-895. 10.5124/jkma.2005.48.9.886.

The New Types of Informed Consent

Affiliations
  • 1Department of Medical Humanities and Social Sciences, University of Ulsan College of Medicine, Korea. jhk@amc.seoul.kr

Abstract

Informed consent is an essential issue in medical practice. Recently, new types of informed consent have emerged from doctor-patient relationship. Genetic studies using patients' specimens are regulated by the "Bioethics and Biosafety Act", which mandates every genetic study be performed with given written informed consent. Clinical trials for drug development are regulated by the Korea Good Clinical Practice, which requires a review and approval process by the Institutional Review Board. Organ donation is regulated by the "Organ Donation Act". Informed consent from family members is important for organ donation of the deceased and minors. It is recommended that terminally ill patients have advance directives, but we do not have relevant legislation on this. New types of informed consent stress the justifiable intervention of the Parens Patriae and neutral third party. Along with the legalization, these should be summarized to prevent unnecessary conflicts.

Keyword

Informed consent; Genetic study; Clinical trial; Advanced directives; Organ donation

MeSH Terms

Advance Directives
Ethics Committees, Research
Humans
Informed Consent*
Korea
Terminally Ill
Tissue and Organ Procurement

Reference

1. Brody Baruch A. The Ethics of Biomedical Research. An International Perspective. 1998. New York. Oxford: 35–54.
3. Chow Shein-Chung, Liu Jen-Pei. Design and Aanalysis of Clinical Trial. 2005. 2nd ed. New-Jersey: Wiley-Interscience;1–34.
4. Hoyer JA. Nondirected kidney donation and its consequences: personal experience of a transplant surgeon. Transplantation. 2003. 76:1264–1265.
Article
5. American College of Legal Medicine Textbook Committee. Legal Medicine. 2004. 6th ed. Philidelphia: Mosby;312–313.
6. Pence Gregory E. Classic Cases in Medical Ethics. 2004. 4ed. New York: Mcgraw Hill;53.
7. SUPPORT Principal Investigator. A Controlled Trial to Improve Care for Seriously Ill Hospitalized Patients. The study to understand Prognoses and Preferences for Outcpmes and Risks of Treatment(SUPPORT). JAMA. 1995. 274:1591–1598.
Full Text Links
  • JKMA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr